US 8937055
Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action
granted A61KA61K31/4418A61K31/4439
Quick answer
US patent 8937055 (Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action) held by Takeda Pharmaceutical Company Limited expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4418, A61K31/4439, A61K31/506, A61K31/5377